NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse

Research output: Contribution to journal › Letter

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{c695f5a2648d4bb4928d4defaceb9a13,

title = "NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse",

author = "S. Clarke and John O'Reilly and Guiliana Romeo and Julian Cooney",

year = "2011",

doi = "10.1016/j.leukres.2011.03.025",

language = "English",

volume = "35",

pages = "e131--e133",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse

AU - Clarke, S.

AU - O'Reilly, John

AU - Romeo, Guiliana

AU - Cooney, Julian

PY - 2011

Y1 - 2011

U2 - 10.1016/j.leukres.2011.03.025

DO - 10.1016/j.leukres.2011.03.025

M3 - Letter

C2 - 21489623

SN - 0145-2126

VL - 35

SP - e131-e133

JO - Leukemia Research

JF - Leukemia Research

IS - 7

ER -